Laird Norton Wetherby Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $601K | Buy |
|
|||||
|
2025
Q2 | $604K | Buy |
|
|||||
|
2024
Q4 | $617K | Sell |
|
|||||
|
2024
Q3 | $585K | Sell |
|
|||||
|
2024
Q2 | $1.05M | Sell |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $866K | Sell |
|
|||||
|
2023
Q3 | $793K | Sell |
|
|||||
|
2023
Q2 | $1.38M | Sell |
|
|||||
|
2023
Q1 | $1.27M | Buy |
|
|||||
|
2022
Q4 | $954K | Sell |
|
|||||
|
2022
Q3 | $1.13M | Buy |
|
|||||
|
2022
Q2 | $1.14M | Sell |
|
|||||
|
2022
Q1 | $1.52M | Sell |
|
|||||
|
2021
Q4 | $1.72M | Buy |
|
|||||
|
2021
Q3 | $1.42M | Buy |
|
|||||
|
2021
Q2 | $1.27M | Buy |
|
|||||
|
2021
Q1 | $973K | Sell |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $935K | Sell |
|
|||||
|
2020
Q2 | $834K | Buy |
|
|||||
|
2020
Q1 | $662K | Sell |
|
|||||
|
2019
Q4 | $852K | Buy |
|
|||||
|
2019
Q3 | $779K | Buy |
|
|||||
|
2019
Q2 | $610K | Buy |
|
|||||
|
2019
Q1 | $626K | Buy |
|
|||||
|
2018
Q4 | $450K | Buy |
|
|||||
|
2018
Q3 | $379K | Sell |
|
|||||
|
2018
Q2 | $323K | Buy |
|
|||||
|
2018
Q1 | $303K | Buy |
|
|||||
|
2017
Q4 | $215K | Buy |
|
|||||
|
2017
Q3 | $206K | Buy |
|
|||||
|
2017
Q2 | $206K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $236K | Buy |
|